Please assess the completion status of the following clinical trial:

Trial Title: Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with newly histologically confirmed non-keratinizing nasopharyngeal carcinoma, including WHO II or III~* Original clinical staged as T1-4N1-3 or T3-4N0（according to the 7th AJCC edition）~* No evidence of distant metastasis (M0)~* Male and no pregnant female~* Age between 18-65~* WBC ≥ 4,000/mm3 and PLT ≥ 100,000/mm3~* With normal liver function test (ALT、AST ≤ 2.5×ULN)~* With normal renal function test (Creatinine ≤ 1.5×ULN)~* Satisfactory performance status: Karnofsky scale (KPS)\> 70~* Without radiotherapy or chemotherapy~* Patients must give signed informed consent~Exclusion Criteria:~* Patients have evidence of relapse or distant metastasis~* The presence of uncontrolled life-threatening illness~* Receiving other ways of anti-cancer therapy~* Receiving radiotherapy or chemotherapy~* Pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Nedaplatin (Type: EXPERIMENTAL): Nedplatin combine with IMRT
- Cisplatin (Type: ACTIVE_COMPARATOR): Cisplatin combine with IMRT

Based on this trial design, predict the completion outcome and termination type (if applicable).